Trimod Therapeutics Ltd. logo

Trimod Therapeutics Ltd.

TriMod Therapeutics Ltd is an early stage biotechnology company developing novel platform technologies to treat cancer and autoimmune diseases.

0
Management
0
Technology
0
Deals/Partnering
0
Research Pipeline
0
Funding
BioStartup's Score 0 / 50

KEY DETAILS

Websitehttp://www.trimodtx.com
Founded2011
Disease Focus
Development Stage
STOCK CODENon Listed
Address
The Tower, Trinity Technology and Enterprise Campus Pearse St
Dublin 2
Ireland
Email
Contact Number

[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=”https://www.linkedin.com/company/trimod-therapeutics” connections=”true” suffix=””]

TriMods proprietary TriMoVav technology is a pre-clinically validated technology that uses the patients own immune system, to target tumours and promotes its eradication by attenuating its immune subversion strategies using a combination of (1) a TLR agonist; (2) a kinase inhibitor; and (3) a tumour antigen of choice. This combination immunotherapy directs the bodys immune system to seek out and destroy tumours present in the body by allowing the selective inhibition of the immunosuppressive, anti-inflammatory and Treg-promoting arm of the innate response.

In Oct. 2011, TriMod has raised ‹750,000 in Seed Capital financing through Enterprise Irelands HPSU program. Originally the company raised money through an Angel investor to develop the treatment.